Mutations in progranulin explain atypical phenotypes with variants in MAPT

S.M. Pickering-Brown, M. Baker, J. Gass, B.F. Boeve, C.T. Loy, W.S. Brooks, I.R.A. Mackenzie, Ralph Martins, J.B.J. Kwok, G.M. Halliday, J. Kril, P.R. Schofield, D.M.A. Mann, M. Hutton

    Research output: Contribution to journalLetter

    85 Citations (Scopus)


    Mutations in presenilin-1 (PSEN1) cause autosomal dominant Alzheimer's disease and mutations in MAPT cause the familial tauopathy Frontotemporal dementia linked to chromosome 17 (FTDP-17). However, there have been reports of mutations in PSEN1 and MAPT associated with cases of FTD with ubiquitin-positive tau-negative inclusion pathology. Here, we demonstrate that the MAPT variants are almost certainly rare benign polymorphisms as all of these cases harbour mutations in Progranulin (PGRN). Mutations in PGRN were recently shown to cause ubiquitin-positive FTDP-17.
    Original languageEnglish
    Pages (from-to)3124-3126
    Publication statusPublished - 2006


    Dive into the research topics of 'Mutations in progranulin explain atypical phenotypes with variants in MAPT'. Together they form a unique fingerprint.

    Cite this